Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population

Cell Biochemistry and Biophysics

Volumn 72, Issue 1, 2015, Pages 221-225

  Li, Chongyi ^a,b   Xiong, Yanli ^a   Zhong, Zhaoyang ^a   Zhang, Shiheng ^a   Peng, Yu ^a   Wang, Lin’ang ^a   Dai, Nan ^a   Li, Mengxia ^a   Ren, Tao ^a   Gan, Lixia ^b   Wang, Dong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ADAMTS5; Chinese; Hepatocellular carcinoma; SNP; Susceptibility

Indexed keywords

ADAMTS5 PROTEIN, HUMAN; AGGRECANASE 2;

ADULT; AGED; ALLELE; CASE CONTROL STUDY; CHINA; DISEASE COURSE; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MISSENSE MUTATION; ODDS RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAMTS5 PROTEIN; ADULT; AGED; ALLELES; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION, MISSENSE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84930414052     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0441-3     Document Type: Article

References (20)

1. Ferlay, J., et al. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer,127(12), 2893–2917.
2. Yano, Y., et al. (2006). Clinical features of hepatitis C virus-related hepatocellular carcinoma and their association with alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II. Liver International,26(7), 789–795.
3. Firpi, R. J., & Nelson, D. R. (2006). Viral hepatitis: Manifestations and management strategy. American Society of Hematology American Society of Hematology Education Program,1, 375–380.
4. Mikhail, S., Cosgrove, D., & Zeidan, A. (2014). Hepatocellular carcinoma: Systemic therapies and future perspectives. Expert Review of Anticancer Therapy,14(10), 1205–1218.
5. Feitelson, M. A. (2006). Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Letters,239(1), 10–20.
6. Shastry, B. S. (2002). SNP alleles in human disease and evolution. Journal of Human Genetics,47(11), 561–566.
7. Buendia, M. A. (2000). Genetics of hepatocellular carcinoma. Seminars in Cancer Biology,10(3), 185–200.
8. Kintakas, C., & McCulloch, D. R. (2011). Emerging roles for ADAMTS5 during development and disease. Matrix Biology,30(5–6), 311–317.
9. Stanton, H., et al. (2005). ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature,434(7033), 648–652.
10. Held-Feindt, J., et al. (2006). Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas. International Journal of Cancer,118(1), 55–61.
11. Cross, N. A., et al. (2005). The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican. Prostate,63(3), 269–275.
12. Porter, S., et al. (2004). Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clinical Cancer Research,10(7), 2429–2440.
13. Kumar, S., et al. (2012). ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity. American Journal of Pathology,181(3), 1056–1068.
14. Sharghi-Namini, S., et al. (2008). The first but not the second thrombospondin type 1 repeat of ADAMTS5 functions as an angiogenesis inhibitor. Biochem Biophys Res Commun,371(2), 215–219.
15. Yue, P., Melamud, E., & Moult, J. (2006). SNPs3D: candidate gene and SNP selection for association studies. BMC Bioinformatics,7, 166.
16. Rodriguez-Lopez, J., et al. (2008). Genetic variation including nonsynonymous polymorphisms of a major aggrecanase, ADAMTS-5, in susceptibility to osteoarthritis. Arthritis and Rheumatism,58(2), 435–441.
17. Peng, Y., et al. (2014). Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients. International Journal of Cancer,135(11), 2687–2696.
18. Sunyaev, S., et al. (2001). Prediction of deleterious human alleles. Human Molecular Genetics,10(6), 591–597.
19. Liu, Q., et al. (2014). Long noncoding RNA related to cartilage injury promotes chondrocyte extracellular matrix degradation in osteoarthritis. Arthritis Rheumatol,66(4), 969–978.
20. Zhang, J., et al. (2014). Transcriptional control of PAX4-regulated miR-144/451 modulates metastasis by suppressing ADAMs expression. Oncogene. doi:10.1038/onc.2014.259.